AmplifiDx
Pleasanton, US · Founded 2020 · Delaware corporation · 2 known investors
AmplifiDx develops point-of-care molecular diagnostic tests and instruments, including its DX 100 platform and multiplex assays for sexual health and family & women's health. The products are designed for use by healthcare professionals and patients to provide rapid results at the point of need.
Digital HealthFemTechHealthtechMedical Devices
Founders & leadership
NS
Nancy SchoenbrunnerChief Executive Officer
MT
Ming TanDirector
SD
Sammy DatwaniDirector
BS
Bruce SargeantDirector
SD
Shoulian DongChief Scientific Officer
DS
Daniel SchoenerChief Product Officer
CM
Chris MedaChief Commercial Officer
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$329.4KraisedJul 2021 · 4 investors · Other Health CareRule 506(b)
▶$329.4KraisedJul 2021 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nancy SchoenbrunnerExecutive Officer, Director
- Ming TanDirector
- Sammy DatwaniDirector
- Bruce SargeantDirector
- Offering amount
- $2.1M
- Amount sold
- $329.4K
- Minimum investment
- $1
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.